Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Immunomodulatory effects of helminths and protozoa in multiple sclerosis and experimental autoimmune encephalomyelitis.
Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation.
The feasibility of collecting information from people with Multiple Sclerosis for the UK MS Register via a web portal: characterising a cohort of people with MS.
Metallic gold slows disease progression, reduces cell death and induces astrogliosis while simultaneously increasing stem cell responses in an EAE rat model of multiple sclerosis.
Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology.
Aquaporin-4 Autoantibodies in Neuromyelitis Optica: AQP4 Isoform-Dependent Sensitivity and Specificity.
Notch Signaling and T-Helper Cells in EAE/MS.
Hypomethylating Agent 5-Aza-2'-deoxycytidine (DAC) Ameliorates Multiple Sclerosis in Mouse Models.
How much sunlight is enough?
The Lateral Membrane Organization and Dynamics of Myelin Proteins PLP and MBP Are Dictated by Distinct Galactolipids and the Extracellular Matrix.
Deep brain stimulation of the ventral intermediate nucleus of the thalamus for tremor in patients with multiple sclerosis.
Effects of Three Months Fingolimod Therapy on Heart Rate.
Anti-drug antibodies: B-cell Immunity against therapy.
Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
Selection and optimization of therapy for progressive type multiple sclerosis.
A modified superantigen rescues Ly6G(-)CD11b(+)blood monocyte suppressor function and suppresses antigen-specific inflammation in EAE.
[Disruption of the blood-brain barrier in inflammatory neurological diseases].
Acute Disseminated Encephalomyelitis Associated With Acute Toxoplasma gondii Infection.
The effects of identification with a support group on the mental health of people with multiple sclerosis.
Editorial comment.
Improvement of interferon-beta related skin reactions after diluent halving: first experience of five patients.
The safety risks of innovation: the FDA's Expedited Drug Development Pathway.
Study protocol: To investigate effects of highly specialized rehabilitation for patients with multiple sclerosis a randomized controlled trial of a personalized, multidisciplinary intervention.
A technical approach to dissecting and assessing cadaveric veins pertinent to chronic cerebrospinal venous insufficiency in multiple sclerosis.
Social and economic burden of walking and mobility problems in multiple sclerosis.

Pages